The Glucagon Like Peptide 1 Analogs Market is driven by growing...

added blog Other

2024-10-31 12:12:52 - Translate -

The Glucagon Like Peptide 1 Analogs Market is driven by growing prevalence of diabetes

The Glucagon Like Peptide 1 (GLP-1) analog market has seen significant growth in recent years. GLP-1 analogs are injectable drugs used to treat type 2 diabetes. They work by stimulating the production of insulin from the pancreas and suppressing glucagon secretion, thereby lowering blood sugar levels. Some key advantages of GLP-1 analogs include weight loss in patients, low risk of...

0 Comments 0 Shares 46 Views 0 Reviews